- Home
- RFL vs NA Comparison
RFL vs NA Comparison
Compare RFL & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- NA
- Stock Information
- Founded
- RFL 2017
- NA 2019
- Country
- RFL United States
- NA China
- Employees
- RFL N/A
- NA N/A
- Industry
- RFL Real Estate
- NA Semiconductors
- Sector
- RFL Finance
- NA Technology
- Exchange
- RFL Nasdaq
- NA Nasdaq
- Market Cap
- RFL 67.7M
- NA 77.6M
- IPO Year
- RFL N/A
- NA 2022
- Fundamental
- Price
- RFL $2.12
- NA $7.79
- Analyst Decision
- RFL
- NA
- Analyst Count
- RFL 0
- NA 0
- Target Price
- RFL N/A
- NA N/A
- AVG Volume (30 Days)
- RFL 296.8K
- NA 1.3M
- Earning Date
- RFL 06-11-2025
- NA 03-25-2025
- Dividend Yield
- RFL N/A
- NA N/A
- EPS Growth
- RFL N/A
- NA N/A
- EPS
- RFL N/A
- NA N/A
- Revenue
- RFL $732,000.00
- NA $5,561,770.00
- Revenue This Year
- RFL N/A
- NA N/A
- Revenue Next Year
- RFL N/A
- NA N/A
- P/E Ratio
- RFL N/A
- NA N/A
- Revenue Growth
- RFL 35.56
- NA N/A
- 52 Week Low
- RFL $1.28
- NA $2.75
- 52 Week High
- RFL $3.19
- NA $31.48
- Technical
- Relative Strength Index (RSI)
- RFL 59.69
- NA 45.47
- Support Level
- RFL $1.83
- NA $7.11
- Resistance Level
- RFL $2.65
- NA $8.36
- Average True Range (ATR)
- RFL 0.18
- NA 2.65
- MACD
- RFL 0.03
- NA -0.50
- Stochastic Oscillator
- RFL 50.73
- NA 2.79
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.